Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Interviews with the Experts Managing MDS With Supportive Care and Active Treatment

    Would you define supportive care and active treatment, and what the differences are between them? ...

    Interview last updated 09/22/2014 - 12:25pm.

  2. Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes

    ... some, most affected patients continue to be treated with supportive care or with drugs that offer temporary palliation such as hematopoietic ...

    Research Article last updated 07/18/2016 - 11:26am.

  3. Ruth Cuadra, survivor and volunteer

    ... with MDS at age 43. In 1998 my only options were supportive care , which meant waiting for my MDS to become leukemia, or transplant. ...

    Patient Chronicle last updated 04/29/2016 - 2:10pm.

  4. Personalized medicine for MDS

    ... and wait” patients require earlier treatment.  Supportive care alone is also a reasonable option for patients who have a short life ...

    Research Review last updated 05/02/2016 - 9:44am.

  5. A Primary Care Approach to Myelodysplastic Syndromes

    ... life expectancy and improve quality of life. Primary care physicians (PCPs) are often involved in the process of diagnosis and ... of life by ensuring early referral and participating in supportive management. There is also a shortage of oncologists which increases ...

    Research Article last updated 06/19/2014 - 12:57pm.

  6. Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management

    ... increasing number of treatment options, ranging from best supportive care to hematopoietic stem cell transplantation (HSCT), decision making is ...

    Research Article last updated 12/09/2015 - 8:45am.

  7. Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes.

    ... analysis compared azacitidine (AZA) to conventional care regimens (CCR) and their associated overall survival (OS) and ... tolerated compared with CCR, which was primarily best supportive care (67%). Grade 3-4 anemia , neutropenia , and ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Outlook and Management of Patients with Myelodysplastic Syndromes Failed by Hypomethylating Agents.

    ... patients with MDS for whom HMAs have failed, including supportive care alone, cytotoxic therapy, lenalidomide , histone deacetylase ...

    Research Article last updated 11/19/2015 - 8:32am.

  9. Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and po

    ...

    Research Article last updated 06/23/2016 - 10:17am.

  10. Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients

    ... study year with 1-year follow-up data. Treatment choices (supportive, active, and transplant) were stratified by the international ... (IPSS-R), then separated into groups by location of care and age (<65 or 65+ years). Academic-based care was any contact with the ...

    Research Article last updated 03/03/2015 - 12:54pm.